Gamma-aminobutyric acid type A receptor alpha6beta3gamma2 subtype (GABA_A receptor α6β3γ2)

The GABA_A receptor α6β3γ2 subtype is a heteropentameric ligand-gated ion channel that serves as a primary mediator of inhibitory neurotransmission in the cerebellum, specifically within the granule cell layer (UniProt: Q16445, P33076, P18507). It is composed of two α6, two β3, and one γ2 subunit, which together form a chloride-selective pore that opens in response to the binding of the neurotransmitter gamma-aminobutyric acid (GABA) (PMID: 8632757). A defining pharmacological feature of this subtype is its insensitivity to classical benzodiazepines like diazepam, a property conferred by the presence of an arginine residue in the α6 subunit where other α subunits possess a histidine (PMID: 16554486). Biologically, α6β3γ2 receptors are involved in phasic inhibition at Golgi-to-granule cell synapses, playing a crucial role in motor control, sensory information filtering, and the regulation of cerebellar-cortical circuits (PMID: 35017178). Dysregulation or hypofunction of these receptors has been implicated in the pathophysiology of essential tremor, cerebellar ataxia, schizophrenia, and chronic tinnitus (PMID: 35017178). Consequently, the development of subtype-selective positive allosteric modulators is an active area of research, aiming to provide therapeutic benefits for motor and neuropsychiatric conditions without the sedative and addictive side effects of non-selective GABAergic agents (PMID: 35017178). These receptors also contribute to the modulation of trigeminal pain and migraine, further expanding their potential as therapeutic targets (PMID: 35017178). Overall, the α6β3γ2 subtype represents a specialized component of the GABAergic system with a restricted expression pattern that allows for highly localized pharmacological intervention.

Other names

GABRA6-GABRB3-GABRG2 complexAlpha6-containing GABA-A receptorDiazepam-insensitive GABA-A receptorGABRA6/GABRB3/GABRG2 heteropentamer

Positive allosteric modulation of the GABA_A receptor chloride channel to enhance inhibitory neurotransmission.